Table 2.
Unadjusted means (SD) for secondary outcomes across the trial
RFA (n=30) | Sham (n=30) | |||||||
---|---|---|---|---|---|---|---|---|
Secondary Outcome* | Baseline | DOS | 2-week FU | 6-week FU | Baseline | DOS | 2-week FU | 6-week FU |
Pain with ambulation | 6.0 (2.4) | 5.2 (2.2) | 3.8 (1.8) | 2.7 (1.8) | 5.8 (1.8) | 5.4 (2.2) | 3.6 (1.7) | 1.9 (1.5) |
PROMIS Physical Function | 37.8 (6.1) | 40.0 (6.0) | 36.3 (4.3) | 41.4 (3.4) | 36.5 (4.9) | 37.1 (4.3) | 37.1 (6.1) | 44.0 (8.3) |
All comparisons for changes from baseline to each follow-up between groups were non-significant based on between-subject t-tests.
DOS, day of surgery; FU, follow-up; PROMIS, Patient Reported Outcome Measurement Information System; RFA, radiofrequency ablation.